Τίτλος:
Phase 1, first-in-human study of MEDI2228, a BCMA-targeted ADC in patients with relapsed/refractory multiple myeloma
Συγγραφείς:
Kumar, Shaji K
Migkou, Magdalini
Bhutani, Manisha
Spencer, Andrew
Ailawadhi, Sikander
Kalff, Anna
Walcott, Farzana
Pore, Nabendu
Gibson, Diana
Wang, Fujun
others